Cavernosal arterial insufficiency is a major component of erectile dysfunction in some recipients of high-dose chemotherapy/chemo-radiotherapy for haematological malignancies
Open Access
- 1 June 2000
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (11) , 1185-1189
- https://doi.org/10.1038/sj.bmt.1702391
Abstract
We studied 24 male patients aged 26–62 years (median 41) prospectively presenting over a 5 year period with clinical features of hypogonadism and erectile dysfunction (ED), who had been treated with autologous or allogeneic bone marrow/stem cell transplant for a variety of haematological malignancies and had received either high-dose chemotherapy or high-dose chemotherapy combined with total body irradiation (TBI). Ten healthy adult controls (aged 35–50 years) were also studied. Erectile dysfunction (ED) was assessed clinically and by colour flow Doppler studies of the cavernosal vessels. Testicular function was assessed by testicular volume including orchidometry, FSH, LH and testosterone measurements. Libido and ejaculatory function were also recorded. Patients had severe hypogonadism as evidenced by low mean testicular volume (7.0 ± 2.4 ml vs 20 ± 2.0 ml; P < 0.001), elevated gonadotrophins (fsh = 18.54 ± 7.61 vs 5 IU/l (P < 0.001); lh = 8.02 ± 2.89 vs 3.9 IU/l (P < 0.001)) and low normal mean testosterone levels (16.4 nmol/l ± 9.1 vs 22.4 nmol/l (P < 0.5)). cavernosal arterial insufficiency was found in 11/14 of tbi-treated and in 3/10 hdc-treated patients, indicative of vasculogenic damage to corpora cavernosal vessels. patients were given a therapeutic trial with testosterone replacement therapy (trt). those who had diminished libido had a marked improvement in their symptoms but the effect of trt on ed was equivocal. in conclusion, this is the first report to show vasculogenic insufficiency in patients with haematological malignancies treated by bmt. although hypogonadism can account for diminished libido, arteriogenic insufficiency is likely to be an important factor accounting for ed in these patients, especially those treated by tbi. we recommend a comprehensive assessment including endocrine profile and colour flow doppler study in formulating the best management plan in recipients of high-dose therapy presenting after transplant with ed. Bone Marrow Transplantation (2000) 25, 1185–1189.Keywords
This publication has 13 references indexed in Scilit:
- MALE HORMONE REPLACEMENT THERAPY INCLUDING “ANDROPAUSE”Endocrinology and Metabolism Clinics of North America, 1998
- The psychosocial impact of bone marrow transplantation: a review of the literatureBone Marrow Transplantation, 1998
- Recent Advances in Clinicaivmolecular AndrologyArchives of Andrology, 1998
- Evaluation of Penile Arteries with Color-Coded Duplex Sonography: Prevalence and Possible Therapeutic Implications of Connections Between Dorsal and Cavernous Arteries in Impotent MenJournal of Urology, 1995
- Correlation of duplex sonography with arteriography in patients with erectile dysfunction.American Journal of Roentgenology, 1993
- An examination of research design effects on the association of testosterone and male aging: Results of a meta-analysisJournal of Clinical Epidemiology, 1991
- Late tissue reactions after single-fraction sequential half-body irradiation (HBI) in patients with non-Hodgkin's lymphomasInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Renal insufficiency after total body irradiation for pediatric bone marrow transplantationRadiotherapy and Oncology, 1990
- History and ExaminationPublished by Springer Nature ,1983
- Synchronization of Augmented Luteinizing Hormone Secretion with Sleep during PubertyNew England Journal of Medicine, 1972